Hepatitis a: Clinical manifestations and management

Intervirology

Volumn 53, Issue 1, 2010, Pages 15-19

  Jeong, Sook Hyang ^a   Lee, Hyo Suk ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Clinical manifestation; Hepatitis A virus; Korea; Management; Prognosis

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEPATITIS A VACCINE;

ACALCULOUS CHOLECYSTITIS; APLASTIC ANEMIA; BLOOD CELL COUNT; CHOLESTASIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIC; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HEMOLYSIS; HEMOLYTIC ANEMIA; HEMOPHILIA; HEPATITIS; HEPATITIS A; HEPATITIS A VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOPROPHYLAXIS; INCIDENCE; KIDNEY FUNCTION TEST; KIDNEY INJURY; KOREA; LIVER TRANSPLANTATION; MALE HOMOSEXUAL; MEDICAL DECISION MAKING; MONONEUROPATHY; PANCREATITIS; PERICARDIAL EFFUSION; PLEURA EFFUSION; PREDICTOR VARIABLE; PREGNANCY; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REACTIVE ARTHRITIS; RELAPSE; VACCINATION;

ADULT; CASE MANAGEMENT; HEPATITIS A; HEPATITIS A VIRUS; HUMANS; KOREA; PROGNOSIS; YOUNG ADULT;

HEPATITIS A VIRUS;

EID: 75349093073     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000252779     Document Type: Conference Paper

References (25)

1. Martin A, Lemon SM: Hepatitis A virus: from discovery to vaccines. Hepatology 2006; 43:S164-S172.
2. Tong MJ, el-Farra NS, Grew MI: Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995; 171(suppl 1):S15-S18.
3. Jeong SH: Current status and vaccine indication for hepatitis A virus infection in Korea (article in Korean). Korean J Gastroenterol 2008; 51: 331-337.
4. Nainan OV, Xia G, Vaughan G, Margolis HS: Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 2006; 19: 63-79.
5. Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, Shapiro CN, Bell BP: Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics 2000; 106:E54.
6. Grinde B, Stene-Johansen K, Sharma B, Hoel T, Jensenius M, Skaug K: Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers: infection by needle sharing? J Med Virol 1997; 53: 69-75.
7. Wheeler C, Vogt TM, Armstrong GL, Vaughan G, Weltman A, Nainan OV, Dato V, Xia G, Waller K, Amon J, Lee TM, Highbaugh-Battle A, Hembree C, Evenson S, Ruta MA, Williams IT, Fiore AE, Bell BP: An outbreak of hepatitis A associated with green onions. N Engl J Med 2005; 353: 890-897.
8. Cooksley WG: Consensus statement on the role of hepatitis A vaccination in patients with chronic liver disease. J Viral Hepat 2000; 7(suppl 1):29-30.
9. Cuthbert JA: Hepatitis A: old and new. Clin Microbiol Rev 2001; 14: 38-58.
10. Sagnelli E, Coppola N, Marrocco C, Onofrio M, Scarano F, Marotta A, Scolastico C, Catuogno A, Salzillo A, Sagnelli C, Piccinino F, Filippini P: HAV replication in acute hepatitis with typical and atypical clinical course. J Med Virol 2003; 71: 1-6.
11. Kim HW, Yu MH, Lee JH, Chang JW, Yang WS, Kim SB, Lee SK, Park JS, Park SK: Experiences with acute kidney injury complicating non-fulminant hepatitis A. Nephrology (Carlton) 2008; 13: 451-458.
12. Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, Dussaix E, Bismuth H, Feray C: Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003; 38: 613-618.
13. Fujiwara K, Yokosuka O, Ehata T, Saisho H, Saotome N, Suzuki K, Okita K, Kiyosawa K, Omata M: Association between severity of type A hepatitis and nucleotide variations in the 5 ′ non-translated region of hepatitis a virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions. Gut 2002; 51: 82-88.
14. Hussain Z, Husain SA, Pasha ST, Anand R, Chand A, Polipalli SK, Rehman S, Kar P: Does mutation of hepatitis A virus exist in North India? Dig Dis Sci 2008; 53: 506-510.
15. Lee D, Cho YA, Park Y, Hwang JH, Kim JW, Kim NY, Lee DH, Lee W, Jeong SH: Hepatitis A in Korea: epidemiological shift and call for vaccine strategy. Intervirology 2008; 51: 70-74.
16. Kim JM, Lee YS, Lee JH, Kim W, Lim KS: Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A (article in Korean). Korean J Hepatol 2008; 14: 474-482.
17. Eisenbach C, Longerich T, Fickenscher H, Schalasta G, Stremmel W, Encke J: Recurrence of clinically significant hepatitis A following liver transplantation for fulminant hepatitis A. J Clin Virol 2006; 35: 109-112.
18. Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D, Ackerman Z: Acute hepatitis a infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006; 130: 1129-1134.
19. Abid S, Khan AH: Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E. Am J Gastroenterol 2002; 97: 1544-1547.
20. Bell BP: Hepatitis A vaccine. Semin Pediatr Infect Dis 2002; 13: 165-173.
21. Almasio PL, Amoroso P: HAV infection in chronic liver disease: a rationale for vaccination. Vaccine 2003; 21: 2238-2241.
22. Jacobsen KH, Koopman JS: Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132: 1005-1022.
23. Wasley A, Samandari T, Bell BP: Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005; 294: 194-201.
24. Orr N, Klement E, Gillis D, Sela T, Kayouf R, Derazne E, Grotto I, Balicer R, Huerta M, Aviram L, Ambar R, Epstein Y, Heled Y, Cohen D: Long-term immunity in young adults after a single dose of inactivated hepatitis A vaccines. Vaccine 2006; 24: 4328-4332.
25. Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP: Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007; 357: 1685-1694.